437 related articles for article (PubMed ID: 24856785)
21. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2011 Jul; 414(1-2):140-7. PubMed ID: 21605644
[TBL] [Abstract][Full Text] [Related]
22. Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.
Freed DC; Towne VM; Casimiro DR; Zhao Q; Fu TM
Vaccine; 2011 Nov; 29(50):9385-90. PubMed ID: 22001120
[TBL] [Abstract][Full Text] [Related]
23. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
Hansen B; Sokolovska A; HogenEsch H; Hem SL
Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
[TBL] [Abstract][Full Text] [Related]
24. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
[TBL] [Abstract][Full Text] [Related]
26. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
Capelle MA; Brügger P; Arvinte T
Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
[TBL] [Abstract][Full Text] [Related]
27. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
28. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
[TBL] [Abstract][Full Text] [Related]
29. Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.
Hassett KJ; Vance DJ; Jain NK; Sahni N; Rabia LA; Cousins MC; Joshi S; Volkin DB; Middaugh CR; Mantis NJ; Carpenter JF; Randolph TW
J Pharm Sci; 2015 Feb; 104(2):627-39. PubMed ID: 25581103
[TBL] [Abstract][Full Text] [Related]
30. Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures.
Fortpied J; Wauters F; Rochart C; Hermand P; Hoet B; Moniotte N; Vojtek I
Hum Vaccin Immunother; 2018 May; 14(5):1243-1250. PubMed ID: 29337646
[TBL] [Abstract][Full Text] [Related]
31. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of ISCOMs for immunization against hepatitis B.
Pandey RS; Dixit VK
Curr Pharm Biotechnol; 2009 Nov; 10(7):709-16. PubMed ID: 19751176
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting alum-protein interactions.
Huang M; Wang W
Int J Pharm; 2014 May; 466(1-2):139-46. PubMed ID: 24607202
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.
Iyer S; Robinett RS; HogenEsch H; Hem SL
Vaccine; 2004 Mar; 22(11-12):1475-9. PubMed ID: 15063571
[TBL] [Abstract][Full Text] [Related]
35. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
Grenfell RF; Shollenberger LM; Samli EF; Harn DA
Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
[TBL] [Abstract][Full Text] [Related]
36. Autoclave-Induced Changes in the Physicochemical Properties and Antigen Adsorption of Aluminum Adjuvants.
Yu G; Yang W; Zhang N; Yang C; Zeng H; Xue C; Sun B
J Pharm Sci; 2024 Feb; 113(2):455-462. PubMed ID: 37813301
[TBL] [Abstract][Full Text] [Related]
37. Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge.
Xiao Y; Zeng Y; Alexander E; Mehta S; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN
Vaccine; 2013 Jan; 31(2):319-26. PubMed ID: 23153450
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
39. Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.
Xu H; Ruwona TB; Thakkar SG; Chen Y; Zeng M; Cui Z
Hum Vaccin Immunother; 2017 Nov; 13(11):2688-2694. PubMed ID: 28933668
[TBL] [Abstract][Full Text] [Related]
40. Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation.
Goyal AK; Rawat A; Mahor S; Gupta PN; Khatri K; Vyas SP
Int J Pharm; 2006 Feb; 309(1-2):227-33. PubMed ID: 16406404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]